GlassScriptPhysician profile
Ray Brock Olson
NPI 1033776562
$2,788.93
in general payments reported to CMS, 2019-2025
21 companies · $614 in 2025
The $614 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.15 · 2022: $640 · 2023: $709 · 2024: $753 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,955 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,955.37 |
| Education | $120.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $521.15 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $405.77 | 2021-2025 | Tezspire, Fasenra |
| Regeneron Healthcare Solutions, INC. | $343.74 | 2022-2025 | Dupixent |
| Amgen INC. | $298.02 | 2022-2025 | Tavneos, Tezspire |
| Abbvie INC. | $194.03 | 2022-2025 | |
| Blueprint Medicines Corporation | $183.86 | 2023 | Ayvakit |
| Novartis Pharmaceuticals Corporation | $161.82 | 2021-2025 | |
| Pharming Healthcare, INC. | $146.86 | 2022 | |
| Inspire Medical Systems, INC. | $145.08 | 2023-2024 | Inspire |
| Sanofi-Aventis U.S. LLC | $120.98 | 2024-2025 | |
| Pfizer INC. | $35.61 | 2023 | |
| Glaxosmithkline, LLC. | $33.98 | 2025 | Trelegy Ellipta |
| Optinose US, INC. | $31.22 | 2022-2024 | |
| Lundbeck LLC | $29.89 | 2023 | Vyepti |
| Takeda Pharmaceuticals U.S.A., INC. | $28.91 | 2024 | Eohilia |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $21.26 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20.71 | 2021 | |
| Med-El Corporation | $19.44 | 2024 | Mi1250 Synchrony 2 Flexsoft, Adhear Professional Kit, Bci 602 Kit |
| Kaleo, INC. | $18.38 | 2024 | Auvi-Q |
| Acella Pharmaceuticals, LLC | $16.13 | 2025 | NP Thyroid 60 |
| Merit Medical Systems INC | $12.09 | 2025 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.